Genedata - Setting up an HCS Data Analysis System: Why You Need One, How to Create One and How it Will Help

High content screening (HCS) is on its way to becoming a standard technology in modern drug discovery. This is especially true in the area of hit identification and confirmation where HCS is an integral part of the screening infrastructure.

Genedata has worked with several major pharmaceutical and biotechnology companies, helping them to establish a complete HCS data analysis (HCA) infrastructure, in alignment with their existing screening data analysis solutions. These customers run or plan to run HCS assays in different formats and throughputs – from lower throughput toxicity, validation or confirmation screens up to full deck library screens with more than 1 million compounds.

Download this free white paper to find out more.